A Comprehensive Review of Coronavirus Disease 2019: Epidemiology, Transmission, Risk Factors, and International Responses

키워드

참고문헌 (100)

1. "Pneumonia of unknown cause – China. WHO 2020 Jan 5"[URL]
2. Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
3. "Novel coronavirus – China"[URL]
4. Wang C, "A novel coronavirus outbreak of global health concern", Lancet, 395, pp.470~473 (2020)
5. "Novel coronavirus (2019-nCoV): situation report-22"[URL]
6. Cucinotta D, "WHO declares COVID-19 a pandemic", Acta Biomed, 91, pp.157~160 (2020)
7. "COVID-19 weekly epidemiological update"[URL]
8. de Wit E, "SARS and MERS : recent insights into emerging coronaviruses", Nat Rev Microbiol, 14, pp.523~534 (2016)
9. Cheng ZJ, "2019 Novel coronavirus : where we are and what we know", Infection, 48, pp.155~163 (2020)
10. Maimuna Majumder, "Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China", SSRN Electronic Journal (2020), Elsevier BV[DOI]
11. "Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"[URL]
12. Tang B, "Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions", J Clin Med, 9, pp.462~ (2020)
13. Chen TM, "A mathematical model for simulating the phase-based transmissibility of a novel coronavirus", Infect Dis Poverty, 9, pp.24~ (2020)
14. "Report 6: relative sensitivity of international surveillance" (2020)[URL]
15. Cimolai N, "More data are required for incubation period, infectivity, and quarantine duration for COVID-19", Travel Med Infect Dis, 37, pp.101713~ (2020)
16. Li Q, "Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia", N Engl J Med, 382, pp.1199~1207 (2020)
17. Lauer SA, "The incubation period of coronavirus disease 2019(COVID-19)from publicly reported confirmed cases : estimation and application", Ann Intern Med, 172, pp.577~582 (2020)
19. "Updated WHO recommendations for international traffic in relation to COVID-19 outbreak"[URL]
20. "Woman in her 70s re-confirmed after 6 days of discharge ... “Estimated recurrence in immunity deterioration”" (2020)[URL]
21. Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
22. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases(COVID-19)in China", Zhonghua Liu Xing Bing Xue Za Zhi, 41, pp.145~151 (2020)
23. Chan JF, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission : a study of a family cluster", Lancet, 395, pp.514~523 (2020)
24. Moein ST, "Smell dysfunction : a biomarker for COVID-19", Int Forum Allergy Rhinol, 10, pp.944~950 (2020)
25. Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study", Lancet, 395, pp.507~513 (2020)
26. Carrillo-Larco RM, "Anosmia and dysgeusia in COVID-19 : a systematic review", Wellcome Open Res, 13(5), pp.94~ (2020)
27. Lechien JR, "Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease(COVID-19) : a multicenter European study", Eur Arch Otorhinolaryngol, 277, pp.2251~2261 (2020)
28. Wilder-Smith A, "Can we contain the COVID-19outbreak with the same measures as for SARS?", Lancet Infect Dis, 20, pp.e102~7 (2020)
29. Cheng PK, "Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome", Lancet, 363, pp.1699~1700 (2004)
30. Gumel AB, "Modelling strategies for controlling SARS outbreaks", Proc Biol Sci, 271, pp.2223~2232 (2004)
31. Wang Z, "Household transmission of SARS-CoV-2", J Infect, 81, pp.179~182 (2020)
32. Wilson-Clark SD, "Household transmission of SARS, 2003", CMAJ, 175, pp.1219~1223 (2006)
33. Lessler J, "Incubation periods of acute respiratory viral infections : a systematic review", Lancet Infect Dis, 9, pp.291~300 (2009)
34. Al-Tawfiq JA, "Viral loads of SARS-CoV, MERS-CoV and SARSCoV-2 in respiratory specimens: what have we learned?", Travel Med Infect Dis, 34, pp.101629~ (2020)
35. Chowell G, "Model parameters and outbreak control for SARS", Emerg Infect Dis, 10, pp.1258~1263 (2004)
36. Shen Z, "Superspreading SARS events, Beijing, 2003", Emerg Infect Dis, 10, pp.256~260 (2004)
37. Stein RA, "Super-spreaders in infectious diseases", Int J Infect Dis, 15, pp.e510~3 (2011)
38. Tomlinson B, "SARS : experience at Prince of Wales Hospital, Hong Kong", Lancet, 361, pp.1486~1487 (2003)
39. Liu Y, "Secondary attack rate and superspreading events for SARS-CoV-2", Lancet, 395, pp.e47~ (2020)
40. "Middle East respiratory syndrome coronavirus (MERSCoV) – Saudi Arabia"[URL]
41. Peeri NC, "The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?", Int J Epidemiol, 49, pp.717~726 (2020)
42. Hemida MG, "Lack of middle East respiratory syndrome coronavirus transmission from infected camels", Emerg Infect Dis, 21, pp.699~701 (2015)
43. Park JE, "MERS transmission and risk factors : a systematic review", BMC Public Health, 18, pp.574~ (2018)
44. Drosten C, "Transmission of MERS-coronavirus in household contacts", N Engl J Med, 371, pp.828~835 (2014)
45. Kim KM, "Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary’s Hospital", Epidemiol Health, 37, pp.e2015041~ (2015)
46. Choi S, "High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks : mathematical modelling in Saudi Arabia and South Korea", J Hosp Infect, 99, pp.162~168 (2018)
47. Chen WQ, "Which preventive measures might protect health care workers from SARS?", BMC Public Health, 9, pp.81~ (2009)
48. Hui DS, "Severe acute respiratory syndrome(SARS) : lessons learnt in Hong Kong", J Thorac Dis, 5(Suppl 2), pp.S122~S126 (2013)
49. Gopalakrishna G, "SARS transmission and hospital containment", Emerg Infect Dis, 10, pp.395~400 (2004)
50. Wax RS, "Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus(2019-nCoV)patients", Can J Anaesth, 67, pp.568~576 (2020)
51. Svoboda T, "Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto", N Engl J Med, 350, pp.2352~2361 (2004)
52. Wiboonchutikul S, "Zero transmission of Middle East respiratory syndrome : lessons learned from Thailand", Clin Infect Dis, 64, pp.S167~70 (2017)
53. Bialek SR, "First confirmed cases of Middle East respiratory syndrome coronavirus(MERS-CoV)infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities-May 2014", MMWR Morb Mortal Wkly Rep, 63, pp.431~436 (2014)
54. Zhou P, "Protecting Chinese healthcare workers while combating the 2019 novel coronavirus", Infect Control Hosp Epidemiol, 41, pp.745~746 (2020)
55. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
56. Prateek Bahl, "Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?", The Journal of Infectious Diseases (2020), Oxford University Press (OUP)[DOI]
57. Jin YH, "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)", Mil Med Res, 7, pp.4~ (2020)
58. Ong J, "Prevention of nosocomial SARS-CoV-2transmission in endoscopy : international recommendations and the need for a gold standard", Gut, 69, pp.1145~1148 (2020)
59. Respiratory Care Committee of Chinese Thoracic Society, "Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia", Zhonghua Jie He He hu Xi Za Zhi, 43, pp.288~296 (2020)
60. Ferioli M, "Protecting healthcare workers from SARS-CoV-2 infection : practical indications", Eur Respir Rev, 29, pp.200068~ (2020)
61. Task Force of Pulmonary Function Testing and Clinical Respiratory Physiology, "Expert consensus on pulmonary function testing during the epidemic of coronavirus disease 2019", Zhonghua Jie He He Hu Xi Za Zhi, 43, pp.302~307 (2020)
62. Luo SH, "A confirmed asymptomatic carrier of 2019 novel coronavirus", Chin Med J(Engl), 133, pp.1123~1125 (2020)
63. Bai Y, "Presumed asymptomatic carrier transmission of COVID-19", JAMA, 323, pp.1406~1407 (2020)
64. Wei WE, "Presymptomatic transmission of SARS-CoV-2-Singapore, January 23-March 16, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.411~415 (2020)
65. Nishiura H, "Serial interval of novel coronavirus(COVID-19)infections", Int J Infect Dis, 93, pp.284~286 (2020)
66. Nishiura H, "Estimation of the asymptomatic ratio of novel coronavirus infections(COVID-19)", Int J Infect Dis, 94, pp.154~155 (2020)
67. "COVID-19 antibody seroprevalence in Santa Clara County, California" (2020)[URL]
68. "Seroprevalence of COVID-19 virus infection in Guilan province, Iran" (2020)[URL]
69. Cheng HY, "Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset", JAMA Intern Med, 180, pp.1156~1163 (2020)
70. "Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis/at:" (2020)[URL]
71. Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019(COVID-19) : a review", JAMA, 324, pp.782~793 (2020)
72. Xu K, "Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019(COVID-19)", Clin Infect Dis, 71, pp.799~806 (2020)
73. Zhou B, "Duration of viral shedding of discharged patients with severe COVID-19", Clin Infect Dis, 71, pp.2240~2242 (2020)
74. Wölfel R, "Virological assessment of hospitalized patients with COVID-2019", Nature, 581, pp.465~469 (2020)
75. He X, "Temporal dynamics in viral shedding and transmissibility of COVID-19", Nat Med, 26, pp.672~675 (2020)
76. Jing QL, "Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China : a retrospective cohort study", Lancet Infect Dis, 20, pp.1141~1150 (2020)
77. Chen T, "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study", BMJ, 368, pp.m1091~ (2020)
78. Jordan RE, "Covid-19: risk factors for severe disease and death", BMJ, 368, pp.m1198~ (2020)
79. Yang J, "Prevalence of comorbidities and its effects in patients infected with SARSCoV-2 : a systematic review and meta-analysis", Int J Infect Dis, 94, pp.91~95 (2020)
80. Wu Z, "Characteristics of and important lessons from the coronavirus disease 2019(COVID-19)outbreak in China : summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention", JAMA, 323, pp.1239~1242 (2020)
81. Wu C, "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China", JAMA Intern Med, 180, pp.934~943 (2020)
82. Chen R, "Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China", Chest, 158, pp.97~105 (2020)
83. Lippi G, "Thrombocytopenia is associated with severe coronavirus disease 2019(COVID-19)infections : a meta-analysis", Clin Chim Acta, 506, pp.145~148 (2020)
84. Cheng Y, "Kidney disease is associated with in-hospital death of patients with COVID-19", Kidney Int, 97, pp.829~838 (2020)
85. Morawska L, "Airborne transmission of SARS-CoV-2 : the world should face the reality", Environ Int, 139, pp.105730~ (2020)
86. Xuejun Jiang, "Asymptomatic SARS‐CoV‐2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days", Journal of Medical Virology, 92(10), pp.1807~1809 (2020), Wiley[DOI]
87. van Doremalen N, "Aerosol and surface stability of SARSCoV-2 as compared with SARS-CoV-1", N Engl J Med, 382, pp.1564~1567 (2020)
88. Guo ZD, "Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020", Emerg Infect Dis, 26, pp.1583~1591 (2020)
89. Wang J, "SARS-CoV-2RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital", Int J Infect Dis, 94, pp.103~106 (2020)
90. Liu Y, "Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals", Nature, 582, pp.557~560 (2020)
91. Pang X, "Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003", JAMA, 290, pp.3215~3221 (2003)
92. ".Availableat:"[URL]
93. "Total COVID-19 tests per 1,000 people. Global Change Data Lab 2020"[URL]
94. "Oxford COVID-19 Government Response Tracker (OxCGRT). COVID-19 Pandemic"[URL]
95. Wang L, "Evaluation of control measures for COVID-19 in Wuhan, China", J Infect, 81, pp.318~356 (2020)
96. "Weekly operational update on COVID-19"[URL]
97. Bell DM, "Public health interventions and SARS spread, 2003", Emerg Infect Dis, 10, pp.1900~1906 (2004)
98. Viner RM, "School closure and management practices during coronavirus outbreaks including COVID-19 : a rapid systematic review", Lancet Child Adolesc Health, 4, pp.397~404 (2020)
99. Jayasundara K, "Natural attack rate of influenza in unvaccinated children and adults : a meta-regression analysis", BMC Infect Dis, 14, pp.670~ (2014)
100. "Age specificity of cases and attack rate of novel coronavirus disease (COVID-19)" (2020)[URL]

관련 논문AI추천